MedPath

Oral and Maxillofacial tissue penetration of Sitafloxacin following oral administration of single 100 mg dose

Not Applicable
Recruiting
Conditions
Impacted third molar teeth
Registration Number
JPRN-UMIN000014556
Lead Sponsor
Department of Dentistry and Oral Surgery, School of Medicine, Keio University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with allergies to any other antibiotics. 2.Patients who are pregnant or trying to get pregnant, or during the breastfeeding. 3.Patients who has disease that needs medical attention in the emergency, or who has liver,kidney and heart failure. 4.Patients with epilepsy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Exam the transfer of Sitafloxacin into serum, gingiva, dental follicles, and madibular bone after 2.0 to 4.5h following oral administration of a single 100mg dose of Sitafloxacin.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath